Radiofrequency ablation for COPD symptoms
Part of Lungs & breathing clinical trials.
This study tests a bronchoscopic treatment that uses radiofrequency energy to reduce COPD symptoms. It may help people who still have breathing problems despite taking medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 85 years old.
- You have COPD with a certain level of breathing obstruction, as shown by a lung function test.
- You have notable symptoms such as shortness of breath or cough, reflected by a score on a questionnaire.
- You have not smoked for at least 2 months and agree not to smoke during the trial.
- You are on standard COPD medication for at least a year and have received a flu shot in the past year or are willing to get one.
- You have no recent severe breathing flares, heart conditions, or other serious health issues that could make the procedure unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device called dNerva that targets nerves in the lungs to help people with COPD breathe easier. It is designed for those who have moderate to severe COPD and are not currently smoking.
This study tests a minimally invasive procedure using a small tube through the mouth to treat chronic bronchitis and reduce flare-ups. It might help people with COPD who still have symptoms on their current medicines.
This trial tests a procedure called Endobronchial Thermal Liquid Ablation (ETLA) that uses heated liquid to treat severe emphysema. It is for people with COPD who have very low lung function and shortness of breath, and who have not been able to get relief from other treatments.
This study compares two minimally invasive treatments—bronchoscopic thermal vapor ablation (BTVA) and microwave ablation (MWA)—for people with COPD and early-stage lung cancer. Both treatments aim to destroy cancer cells without surgery, which may be a good option if you cannot or prefer not to have surgery.
This study tests whether a new approach can help relieve severe shortness of breath in people with COPD who are already on standard inhaler therapy. It may help you breathe easier and improve your daily life.
This study tests whether a structured care program for COPD can lower how often your symptoms flare up. It may help by improving everyday management and preventing future worsening.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.